Goepferich A - Search Results

1

Towards a Switchable Nanoparticle Behavior Using Inverse Electron-Demand Diels-Alder Chemistry and Ectoenzyme-Based Ligand Activation.

Lang J, Schorr K, Goepferich A. Lang J, et al. Among authors: goepferich a. Eur J Pharm Sci. 2024 Oct 24:106944. doi: 10.1016/j.ejps.2024.106944. Online ahead of print. Eur J Pharm Sci. 2024. PMID: 39461601 Free article.

2

Rethinking Thin-Layer Chromatography for Screening Technetium-99m Radiolabeled Polymer Nanoparticles.

Schorr K, Chen X, Sasaki T, Arias-Loza AP, Lang J, Higuchi T, Goepferich A. Schorr K, et al. Among authors: goepferich a. ACS Pharmacol Transl Sci. 2024 Aug 30;7(9):2604-2611. doi: 10.1021/acsptsci.4c00383. eCollection 2024 Sep 13. ACS Pharmacol Transl Sci. 2024. PMID: 39296255

3

Long-term residence and efficacy of adenovirus-mimetic nanoparticles in renal target tissue.

Walter M, Weißbach H, Gembardt F, Halder S, Schorr K, Fleischmann D, Todorov V, Hugo C, Goepferich A. Walter M, et al. Among authors: goepferich a. J Drug Target. 2024 Aug 22:1-13. doi: 10.1080/1061186X.2024.2390628. Online ahead of print. J Drug Target. 2024. PMID: 39171543

4

Conditional Cell-Penetrating Peptide Exposure as Selective Nanoparticle Uptake Signal.

Walter M, Bresinsky M, Zimmer O, Pockes S, Goepferich A. Walter M, et al. Among authors: goepferich a. ACS Appl Mater Interfaces. 2024 Jul 24;16(29):37734-37747. doi: 10.1021/acsami.4c07821. Epub 2024 Jul 15. ACS Appl Mater Interfaces. 2024. PMID: 39010308 Free PMC article.

5

Prolonged delivery of HIV-1 vaccine nanoparticles from hydrogels.

Mietzner R, Barbey C, Lehr H, Ziegler CE, Peterhoff D, Wagner R, Goepferich A, Breunig M. Mietzner R, et al. Among authors: goepferich a. Int J Pharm. 2024 May 25;657:124131. doi: 10.1016/j.ijpharm.2024.124131. Epub 2024 Apr 21. Int J Pharm. 2024. PMID: 38643811 Free article.

6

On the uncertainty of the correlation between nanoparticle avidity and biodistribution.

Zimmer O, Goepferich A. Zimmer O, et al. Among authors: goepferich a. Eur J Pharm Biopharm. 2024 May;198:114240. doi: 10.1016/j.ejpb.2024.114240. Epub 2024 Mar 2. Eur J Pharm Biopharm. 2024. PMID: 38437906 Free article. Review.

7

Ectoenzymes as promising cell identification structures for the high avidity targeting of polymeric nanoparticles.

Walter M, Baumann F, Schorr K, Goepferich A. Walter M, et al. Among authors: goepferich a. Int J Pharm. 2023 Nov 25;647:123453. doi: 10.1016/j.ijpharm.2023.123453. Epub 2023 Sep 30. Int J Pharm. 2023. PMID: 37783283

8

Impact of interferon-γ on the target cell tropism of nanoparticles.

Zimmer O, Walter M, Remmert M, Maier O, Witzgall R, Goepferich A. Zimmer O, et al. Among authors: goepferich a. J Control Release. 2023 Oct;362:325-341. doi: 10.1016/j.jconrel.2023.08.034. Epub 2023 Sep 2. J Control Release. 2023. PMID: 37598888

9

Intravenous injection of cyclosporin A loaded lipid nanocapsules fights inflammation and immune system activation in a mouse model of diabetic retinopathy.

Bohley M, Dillinger AE, Braunger BM, Tamm ER, Goepferich A. Bohley M, et al. Among authors: goepferich a. Drug Deliv Transl Res. 2023 Nov;13(11):2807-2818. doi: 10.1007/s13346-023-01350-7. Epub 2023 May 19. Drug Deliv Transl Res. 2023. PMID: 37208562 Free PMC article.

10

Encapsulation of Pioglitazone into Polymer-Nanoparticles for Potential Treatment of Atherosclerotic Diseases.

Groner J, Tognazzi M, Walter M, Fleischmann D, Mietzner R, Ziegler CE, Goepferich AM, Breunig M. Groner J, et al. Among authors: goepferich am. ACS Appl Bio Mater. 2023 Jun 19;6(6):2111-2121. doi: 10.1021/acsabm.2c01001. Epub 2023 May 5. ACS Appl Bio Mater. 2023. PMID: 37145591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters